GENEVA, Dec. 29 -- UROVANT SCIENCES GMBH (Aeschengraben 274051 Basel) filed a patent application (PCT/IB2025/056180) for "CRYSTALLINE FORM OF VIBEGRON HEMIHYDRATE" on Jun 17, 2025. With publication no. WO/2025/262600, the details related to the patent application was published on Dec 26, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): ZHANG, Haitao (c/o UROVANT SCIENCES GMBHAeschengraben 274051 Basel)
Abstract: Described herein is a crystalline form of a hemihydrate of the Beta-3 adrenergic receptor agonist vibegron. The disclosure also relates to preparations of the crystalline form, pharm...